SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses by Weiyi Tang, Zi Wei Chang, Yun Shan Goh, Yong Jie Tan, Pei Xiang Hor, Chiew Yee Loh, David C. Lye, Barnaby E. Young, Lisa F. P. Ng, Matthew Zirui Tay, Laurent Rénia, on behalf of the COVID-19 Cohort Study Group, NCID Study Group, COVID Clinicians’ Group

Get full text